Back to funds
View filing
Lion Point Capital, LP
hedge fundUpdated 30 days agoManaged by Lion Point Capital, Lp • Latest filing Q2 2026
Portfolio value
$20.9M
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
-60.2%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $242.9M |
| Q2 2023 | $221.3M |
| Q3 2023 | $224.4M |
| Q4 2023 | $199.9M |
| Q1 2024 | $179M |
| Q2 2024 | $54.9M |
| Q3 2024 | $44.9M |
| Q4 2024 | $19.1M |
| Q1 2025 | $15.7M |
| Q2 2025 | $14.7M |
| Q3 2025 | $17.6M |
| Q4 2025 | $19.3M |
| Q1 2026 | $16.7M |
| Q2 2026 | $20.9M |
Top holdings
35 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | ? N/A CUE BIOPHARMA INC | $1.7M | 52.9K | 7.99% | — |
| 2 | P PRAX PRAXIS PRECISION MEDICINES I | $1.5M | 4.5K | 7.13% | — |
| 3 | M MLTX MOONLAKE IMMUNOTHERAPEUTICS | $1.3M | 67.5K | 6.29% | — |
| 4 | F FENC FENNEC PHARMACEUTICALS INC | $1.2M | 112.4K | 5.78% | — |
| 5 | R RPRX ROYALTY PHARMA PLC | $1.2M | 21.4K | 5.74% | — |
| 6 | C CMPS COMPASS PATHWAYS PLC | $1.1M | 80.0K | 5.41% | — |
| 7 | M MIST MILESTONE PHARMACEUTICALS IN | $1.1M | 820.0K | 5.26% | — |
| 8 | B BNTC BENITEC BIOPHARMA INC | $830K | 62.0K | 3.97% | — |
| 9 | S SNDX SYNDAX PHARMACEUTICALS INC | $787K | 36.0K | 3.76% | — |
| 10 | B BHVN BIOHAVEN LTD | $769K | 51.7K | 3.68% | — |
| 11 | G GERN GERON CORP | $740K | 578.0K | 3.54% | — |
| 12 | Q QURE UNIQURE NV | $677K | 14.7K | 3.24% | — |
| 13 | A ARDX ARDELYX INC | $656K | 128.7K | 3.14% | — |
| 14 | L LNTH LANTHEUS HLDGS INC | $610K | 5.5K | 2.92% | — |
| 15 | I IRON DISC MEDICINE INC | $592K | 8.1K | 2.83% | — |
| 16 | S SAY SAREPTA THERAPEUTICS INC | $512K | 28.5K | 2.45% | — |
| 17 | H HUMAW HUMACYTE INC | $507K | 650.0K | 2.43% | — |
| 18 | K KURA KURA ONCOLOGY INC | $505K | 46.0K | 2.41% | — |
| 19 | V VTRS VIATRIS INC | $440K | 27.7K | 2.10% | — |
| 20 | D DYN DYNE THERAPEUTICS INC | $400K | 18.0K | 1.91% | — |